Developing Medical Devices to Treat Pain - Helping to End Addiction Long-term (HEAL)

NIH HEAL Initiative

NIBIB is playing a major role in the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-termSM) Initiative, a trans-agency effort focused on improving prevention and treatment strategies for opioid misuse and addiction and enhancing pain management. Launched in April 2018 with funding from Congress, the HEAL Initiative brings new hope for people, families, and communities affected by the national opioid public health crisis.

New HEAL Initiative funding opportunity announcement

In this video, Bruce Tromberg, Ph.D., director of the National Institue for Biomedical Imaging and Bioengineering, and Helene Langevin, M.D., director of the National Center for Complementary and Integrative Health, introduce a new funding opportunity from the NIH HEAL®(Helping to End Addiction Long-term) Initiative that will focus on the development of innovative quantitative imaging and relevant biomarkers of myofascial tissues for pain management.

Funding Opportunities

Funding Opportunity Announcements (FOAs)

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33 Clinical Trial Required)
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
Webinar written on image

Webinars

Three webinars were held on December 2018 that introduced the audience to the funding opportunity announcements (FOAs), all seeking to develop medical devices to treat pain.  These FOAs support different degrees of technological maturity.  All focus on approaches that target the nervous system to provide the therapeutic, rehabilitative, or diagnostic capability.  

Click here to download webinar slides

Program Contacts

Moria Bittman, Ph.D., Program Director, NIBIB

Nick Langhals, Ph.D., Program Director, NINDS

Kari Ashmont, Ph.D., Scientific Project Manager, NINDS

Eric Hudak, Ph.D., Scientific Project Manager, NINDS​​​​

lecture audience raising hands

Frequently Asked Questions

Get answers to Frequently Asked Questions about the Developing Medical Devices to Treat Pain research program.

Related News

September 22, 2021
illustration of focused ultrasound targeting specific neurons in the brain
NIBIB-funded engineers are using focused ultrasound to modulate motor activity in the brain without surgical device implantation, a first step toward non-invasive brain stimulation therapies.
August 10, 2021
Artists rendering of a synapse
NIH-funded researchers at Carnegie Mellon University have demonstrated the potential of a neuromodulation approach that uses low-intensity ultrasound energy, called transcranial focused ultrasound—or tFUS.
May 6, 2021
New research demonstrates that noninvasive neuromodulation via low-intensity ultrasound can have cell-type selectivity in manipulating neurons.
May 18, 2020
neuron
Researchers at the University of Wisconsin (UW) are adapting a minimally invasive, safer approach to electrically treat pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.
November 12, 2019
Electrically stimulating nerves can reduce epileptic seizures, soothe chronic pain, and treat depression. Now, biomedical engineers have made a significant advance that could dramatically reduce the cost of neuromodulation therapy, increase its reliability and make it much less invasive.